SCHEMBL3625149

SCHEMBL3625149

CCOC(=O)C(=NOC)c1ccccc1CCl

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 8/20 0.47
TSHR P16473 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PKM P14618 1/20 0.40
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
PLIN1 O60240 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
PLIN5 Q00G26 1/20 0.39
ABHD5 Q8WTS1 1/20 0.39
HSD17B10 Q99714 1/20 0.38
GPR35 Q9HC97 1/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8203671 1.00 HIF1A (0.47) HIF1ATSHRMEN1KMT2ASMN1; SMN2
SCHEMBL3625146 1.00 HIF1A (0.47) HIF1ATSHRMEN1KMT2ASMN1; SMN2
SCHEMBL5598036 0.89 HIF1A (0.46) HIF1ATSHRSMN1; SMN2ALDH1A1LMNA
SCHEMBL29765456 0.87 HIF1A (0.60) HIF1ATSHRALDH1A1LMNAPOLB
SCHEMBL3311081 0.87 HIF1A (0.60) HIF1ATSHRALDH1A1LMNAPOLB
SCHEMBL29765448 0.87 HIF1A (0.60) HIF1ATSHRALDH1A1LMNAPOLB
SCHEMBL3621124 0.87 HIF1A (0.60) HIF1ATSHRALDH1A1LMNAPOLB
SCHEMBL5597762 0.87 TSHR (0.48) HIF1ATSHRSMN1; SMN2ALDH1A1LMNA
SCHEMBL8613981 0.86 HIF1A (0.53) HIF1ATSHRMEN1KMT2ASMN1; SMN2
SCHEMBL7773929 0.86 HIF1A (0.47) HIF1ATSHRMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0765304-B2 METHOD OF PREPARING ALPHA-METHOXYIMINOCARBOXYLIC ACID METHYLAMIDES, AND INTERMEDIATES USED IN THE METHOD BAYER CROPSCIENCE AG (DE) 2007-08-22 EP claimed
EP-2393775-B1 METHOD FOR PRODUCING 2-HALOGENOMETHYLPHENYL ACETIC ACID DERIVATIVES BASF SE (DE) 2014-06-25 EP disclosed
US-8575366-B2 Method for producing 2-halogenomethylphenyl acetic acid derivatives BASF SE (DE) 2013-11-05 US disclosed
EP-2393775-A2 METHOD FOR PRODUCING 2-HALOGENOMETHYLPHENYL ACETIC ACID DERIVATIVES BASF SE (DE) 2011-12-14 EP disclosed
US-20110295022-A1 Method for producing 2-halogenomethylphenyl acetic acid derivatives BASE SE (DE) 2011-12-01 US disclosed
WO-2010089267-A2 METHOD FOR PRODUCING 2-HALOGENOMETHYLPHENYL ACETIC ACID DERIVATIVES BASF SE (DE) 2010-08-12 WO disclosed
US-6124493-A Process for the preparation of o-chloromethyl-phenylglyoxylic acid derivatives NOVARTIS FINANCE CORPORATION (US) 2000-09-26 US disclosed
US-5756811-A Process for the preparation of o-chloromethyl-phenylglyoxylic acid derivatives NOVARTIS CORPORATION (US) 1998-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110295022-A1 Method for producing 2-halogenomethylphenyl acetic acid derivatives HACL2, AKR7A2, ALAD HIF1A 2859/4885TSHR 1109/4885MEN1 3204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.